Related references
Note: Only part of the references are listed.The extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB/c mice
Xiaojing Sun et al.
BMC INFECTIOUS DISEASES (2014)
The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice
Bin Zheng et al.
VACCINE (2013)
Toxoplasma gondii: The vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice
Bozena Dziadek et al.
EXPERIMENTAL PARASITOLOGY (2012)
DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice
Xi-Meng Sun et al.
PARASITES & VECTORS (2011)
Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii
Elzbieta Hiszczynska-Sawicka et al.
VETERINARY PARASITOLOGY (2011)
CD8+ T cells are the major lymphocyte subpopulatlon involved in the protective immune response to Toxoplasma gondii in mice
S. J. PARKER et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?
Elisabeth A. Innes
EXPERT REVIEW OF VACCINES (2010)
Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles
Brian R. Sloat et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Toxoplasma gondii: The immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis
Bozena Dziadek et al.
EXPERIMENTAL PARASITOLOGY (2009)
Current status of toxoplasmosis vaccine development
Jozef Kur et al.
EXPERT REVIEW OF VACCINES (2009)
Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii
Rui Chen et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2009)
GRA Proteins of Toxoplasma gondii: Maintenance of Host-Parasite Interactions across the Parasitophorous Vacuolar Membrane
Ho-Woo Nam
KOREAN JOURNAL OF PARASITOLOGY (2009)
Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice
Shan Liu et al.
PARASITOLOGY RESEARCH (2009)
Toxoplasma gondii:: Evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice
M. Igarashi et al.
EXPERIMENTAL PARASITOLOGY (2008)
Toxoplasma gondii: cloning, sequencing, expression, and antigenic characterization of ROP2, GRA5 and GRA7
M. Igarashi et al.
GENETICS AND MOLECULAR RESEARCH (2008)
Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii
Mingfu Xue et al.
PARASITOLOGY INTERNATIONAL (2008)
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice
Majid Golkar et al.
VACCINE (2007)
Toxoplasma gondii:: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris
Huaiyu Zhou et al.
PARASITOLOGY RESEARCH (2007)
Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein
Pablo Christian Echeverria et al.
VACCINE (2006)
Adjuvants and antibody production: Dispelling the myths associated with Freund's complete and other adjuvants
HF Stills
ILAR JOURNAL (2005)
Development of a vaccine for toxoplasmosis: current status
GM Bhopale
MICROBES AND INFECTION (2003)
A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection
T Scorza et al.
INFECTION AND IMMUNITY (2003)
Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3
DJ Lefeber et al.
INFECTION AND IMMUNITY (2003)
The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis
AB Ismael et al.
INFECTION AND IMMUNITY (2003)
Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis
PH Feng et al.
JOURNAL OF VIROLOGY (2002)
Toxoplasma gondii:: transmission, diagnosis and prevention
D Hill et al.
CLINICAL MICROBIOLOGY AND INFECTION (2002)
Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice
LL Johnson et al.
INFECTION AND IMMUNITY (2002)
B cell immunodeficiency fails to develop in CD4-Deficient mice infected with BM5: Murine AIDS as a multistep disease
DP Harris et al.
JOURNAL OF IMMUNOLOGY (2001)
B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii
PC Sayles et al.
INFECTION AND IMMUNITY (2000)
Share Paper
